Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin

[1]  J. Verhoef,et al.  Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid , 1983, European Journal of Clinical Microbiology.

[2]  J. Verhoef,et al.  Defects of phagocytic cells in patients with iron overload , 1982, Antonie van Leeuwenhoek.

[3]  B. V. van Oost,et al.  Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. , 1982, British medical journal.

[4]  D. Schlessinger,et al.  The assessment of antimicrobial combinations. , 1981, Reviews of infectious diseases.

[5]  A. Nienhuis.  Vitamin C and iron. , 1981, The New England journal of medicine.

[6]  H. Versteeg,et al.  Semielectronic turbidimeter for automated monitoring of bacterial growth in test tubes , 1980, Applied and environmental microbiology.

[7]  R. Finkelstein,et al.  The critical role of iron in host-bacterial interactions. , 1978, The Journal of clinical investigation.

[8]  E. Weinberg.  Iron and infection , 1978, Microbiological reviews.

[9]  D. Rosenthal,et al.  Treatment of iron overload in adults with continuous parenteral desferrioxamine. , 1977, The American journal of medicine.

[10]  W. Anderson,et al.  Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron Overload , 1977 .

[11]  J. Klastersky,et al.  Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial. , 1976, The Journal of infectious diseases.

[12]  A. Lerner,et al.  Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. , 1976, The Journal of infectious diseases.

[13]  Charlton Rw,et al.  Iron, ascorbic acid, and thalassemia. , 1976 .

[14]  W. Anderson,et al.  Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload. , 1976, Birth defects original article series.

[15]  T. Bothwell,et al.  Iron, ascorbic acid, and thalassemia. , 1976, Birth defects original article series.

[16]  R. O'brien.  ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR * , 1974, Annals of the New York Academy of Sciences.

[17]  C. E. Lankford,et al.  Bacterial Assimilation of iron , 1973 .

[18]  J. Neilands.  Evolution of biological iron binding centers , 1972 .

[19]  E. Weinberg.  Roles of Iron in Host-Parasite Interactions , 1971 .

[20]  H. Keberle.  The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism , 1964, Annals of the New York Academy of Sciences.